Molecular characteristics of eae-positive clinical Shiga toxin-producing Escherichia coli in Sweden

Emerg Microbes Infect. 2020 Dec;9(1):2562-2570. doi: 10.1080/22221751.2020.1850182.

Abstract

Shiga toxin (Stx)-producing Escherichia coli (STEC) can cause a wide range of symptoms from asymptomatic carriage, mild diarrhea to bloody diarrhea (BD) and hemolytic uremic syndrome (HUS). Intimin, encoded by the eae gene, also plays a critical role in STEC pathogenesis. Herein, we investigated the prevalence and genetic diversity of eae among clinical STEC isolates from patients with diarrhea, BD, HUS as well as from asymptomatic STEC-positive individuals in Sweden with whole-genome sequencing. We found that 173 out of 239 (72.4%) of clinical STEC strains were eae positive. Six eae subtypes (ϵ1, γ1, β3, θ, ζ and ρ) were identified eae and its subtype γ1 were significantly overrepresented in O157:H7 strains isolated from BD and HUS patients. ϵ1 was associated with O121:H19 and O103:H2 strains, and β3 to O26:H11 strains. The combination of eae subtype γ1 and stx subtype (stx 2 or stx 1+stx 2) is more likely to cause severe disease, suggesting the possibility of using eae genotypes in risk assessment of STEC infection. In summary, this study demonstrated a high prevalence of eae in clinical STEC strains and considerable genetic diversity of eae in STEC strains in Sweden from 1994 through 2018, and revealed association between eae subtypes and disease severity.

Keywords: eae gene; Shiga toxin-producing Escherichia coli; clinical significance; gene diversity; hemolytic uremic syndrome; intimin.

MeSH terms

  • Adhesins, Bacterial / genetics*
  • Bacterial Typing Techniques
  • Diarrhea / microbiology*
  • Escherichia coli Infections / epidemiology*
  • Escherichia coli Proteins / genetics*
  • Hemolytic-Uremic Syndrome / microbiology*
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Phylogeny
  • Population Surveillance
  • Prevalence
  • Serotyping
  • Shiga-Toxigenic Escherichia coli / classification*
  • Shiga-Toxigenic Escherichia coli / genetics
  • Shiga-Toxigenic Escherichia coli / isolation & purification
  • Sweden / epidemiology
  • Whole Genome Sequencing

Substances

  • Adhesins, Bacterial
  • Escherichia coli Proteins
  • eaeA protein, E coli

Grants and funding

This work was supported by the Scandinavian Society for Antimicrobial Chemotherapy Foundation [grant number SLS884041], National Natural Science Foundation of China [grant number 81701977], and the Natural Science Foundations of Guangdong Province [grant number 2018B030311063 and 2019A1515111004]. All funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.